Lièvre A - Search Results

1

AGR2 protein expression in colorectal tumour epithelialcompartment.

Chevet E, Bassal F, Beq S, Bonhomme B, Boisteau E, Calloch J, Cazals-Hatem D, Delom F, Fessart D, Evrard S, Hrstka R, Hupp T, Lièvre A, Louis E, Mariau J, Meuwis MA, Ogier-Denis E, Paradis V, Pernot S, Pineau R, Treton X, Velasco V, Vieujean S. Chevet E, et al. Among authors: lievre a. Gut. 2022 Dec 9;72(12):2385-6. doi: 10.1136/gutjnl-2022-328739. Online ahead of print. Gut. 2022. PMID: 36591613 Free PMC article. No abstract available.

2

Management of T1 colorectal cancers detected at screening colonoscopy: A study from the French national screening programme.

Grainville T, Bretagne JF, Piette C, Rousseau C, Bordet M, Cosson M, Lièvre A. Grainville T, et al. Among authors: lievre a. Dig Liver Dis. 2020 Aug;52(8):909-917. doi: 10.1016/j.dld.2020.04.022. Epub 2020 Jun 3. Dig Liver Dis. 2020. PMID: 32505572 Free article.

3

Fecal immunological blood test is more appealing than the guaiac-based test for colorectal cancer screening.

Le Pimpec F, Moutel G, Piette C, Lièvre A, Bretagne JF. Le Pimpec F, et al. Among authors: lievre a. Dig Liver Dis. 2017 Nov;49(11):1267-1272. doi: 10.1016/j.dld.2017.08.018. Epub 2017 Aug 10. Dig Liver Dis. 2017. PMID: 28867474

4

Clinicopathological significance of mitochondrial D-Loop mutations in head and neck carcinoma.

Lièvre A, Blons H, Houllier AM, Laccourreye O, Brasnu D, Beaune P, Laurent-Puig P. Lièvre A, et al. Br J Cancer. 2006 Mar 13;94(5):692-7. doi: 10.1038/sj.bjc.6602993. Br J Cancer. 2006. PMID: 16495928 Free PMC article.

5

[Predictive factors of response to anti-EGFR treatments in colorectal cancer].

Lièvre A, Laurent-Puig P. Lièvre A, et al. Bull Cancer. 2008 Jan;95(1):133-40. doi: 10.1684/bdc.2008.0551. Bull Cancer. 2008. PMID: 18230579 Free article. Review. French.

6

Apport de l'immunothérapie dans le traitement des cancers des voies biliaires avancés.

Delaye M, Lièvre A, Neuzillet C. Delaye M, et al. Among authors: lievre a. Bull Cancer. 2022 Nov;109(11S):11S11-11S20. doi: 10.1016/S0007-4551(22)00464-7. Bull Cancer. 2022. PMID: 36535758 Free article. Review. French.

7

A robust enzyme-linked immunosorbent assay to measure serum ramucirumab concentrations.

Desvignes C, Ternant D, Lecomte T, Lièvre A, Ohresser M, Chautard R, Raoul W, Paintaud G. Desvignes C, et al. Among authors: lievre a. Bioanalysis. 2021 Apr;13(7):565-574. doi: 10.4155/bio-2020-0199. Epub 2021 Mar 26. Bioanalysis. 2021. PMID: 33769095 Free article.

8

[The biological point of view on pharmacogenetics of anticancer agents in colorectal cancer].

Laurent-Puig P, Lièvre A, Ducreux M, Loriot MA. Laurent-Puig P, et al. Among authors: lievre a. Bull Cancer. 2008 Oct;95(10):935-42. doi: 10.1684/bdc.2008.0728. Bull Cancer. 2008. PMID: 19004723 Free article. French.

9

PRODIGE 59-DURIGAST trial: A randomised phase II study evaluating FOLFIRI + Durvalumab ± Tremelimumab in second-line of patients with advanced gastric cancer.

Evrard C, Louvet C, Hajbi FE, Fiore FD, Malicot KL, Aparicio T, Bouché O, Laurent-Puig P, Bibeau F, Lecomte T, Lièvre A, Guimbaud R, Kim S, Zaanan A, Sokol H, Chibaudel B, Desrame J, Pierre S, Gonzalez D, Lepage C, Tougeron D. Evrard C, et al. Among authors: lievre a. Dig Liver Dis. 2021 Apr;53(4):420-426. doi: 10.1016/j.dld.2020.11.036. Epub 2021 Jan 6. Dig Liver Dis. 2021. PMID: 33358124 Free article. Clinical Trial.

10

Clinical value of mitochondrial mutations in colorectal cancer.

Lièvre A, Chapusot C, Bouvier AM, Zinzindohoué F, Piard F, Roignot P, Arnould L, Beaune P, Faivre J, Laurent-Puig P. Lièvre A, et al. J Clin Oncol. 2005 May 20;23(15):3517-25. doi: 10.1200/JCO.2005.07.044. J Clin Oncol. 2005. PMID: 15908662

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

169 results

Search Page